Guardian Pharmacy [GRDN] vs Acadia Healthcare [ACHC] Detailed Stock Comparison

Guardian Pharmacy
NYSE
Loading...

Acadia Healthcare
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Guardian Pharmacy wins in 6 metrics, Acadia Healthcare wins in 12 metrics, with 0 ties. Acadia Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Guardian Pharmacy | Acadia Healthcare | Better |
---|---|---|---|
P/E Ratio (TTM) | 90.13 | 13.80 | Acadia Healthcare |
Price-to-Book Ratio | 9.28 | 0.62 | Acadia Healthcare |
Debt-to-Equity Ratio | 22.18 | 74.74 | Guardian Pharmacy |
PEG Ratio | -6.39 | -0.22 | Guardian Pharmacy |
EV/EBITDA | -43.48 | 6.76 | Guardian Pharmacy |
Profit Margin (TTM) | -5.19% | 4.31% | Acadia Healthcare |
Operating Margin (TTM) | 4.38% | 16.37% | Acadia Healthcare |
EBITDA Margin (TTM) | 4.38% | 16.37% | Acadia Healthcare |
Return on Equity | -52.74% | 4.83% | Acadia Healthcare |
Return on Assets (TTM) | -10.92% | 4.92% | Acadia Healthcare |
Free Cash Flow (TTM) | $41.59M | $-560.69M | Guardian Pharmacy |
1-Year Return | 48.11% | -73.19% | Guardian Pharmacy |
Price-to-Sales Ratio (TTM) | 1.19 | 0.60 | Acadia Healthcare |
Enterprise Value | $1.60B | $4.36B | Acadia Healthcare |
EV/Revenue Ratio | 1.21 | 1.35 | Guardian Pharmacy |
Gross Profit Margin (TTM) | 19.79% | 96.72% | Acadia Healthcare |
Revenue per Share (TTM) | $21 | $35 | Acadia Healthcare |
Earnings per Share (Diluted) | $-1.48 | $1.52 | Acadia Healthcare |
Beta (Stock Volatility) | N/A | 0.88 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Guardian Pharmacy vs Acadia Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Guardian Pharmacy | 0.92% | 10.05% | 25.85% | 19.17% | 34.27% | 32.18% |
Acadia Healthcare | 0.56% | 3.68% | -1.02% | -8.89% | -45.98% | -47.46% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Guardian Pharmacy | 48.11% | 48.11% | 48.11% | 48.11% | 48.11% | 48.11% |
Acadia Healthcare | -73.19% | -74.08% | -31.41% | -71.29% | 353.81% | 114.20% |
Performance & Financial Health Analysis: Guardian Pharmacy vs Acadia Healthcare
Metric | GRDN | ACHC |
---|---|---|
Market Information | ||
Market Cap | $1.57B | $1.94B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 224,706 | 3,251,860 |
90 Day Avg. Volume | 158,499 | 2,130,137 |
Last Close | $26.29 | $21.42 |
52 Week Range | $14.16 - $26.91 | $17.13 - $82.41 |
% from 52W High | -2.30% | -74.01% |
All-Time High | $26.91 (May 05, 2025) | $89.85 (Nov 28, 2022) |
% from All-Time High | -2.30% | -76.16% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.15% | 0.09% |
Quarterly Earnings Growth | -0.15% | -0.62% |
Financial Health | ||
Profit Margin (TTM) | -0.05% | 0.04% |
Operating Margin (TTM) | 0.04% | 0.16% |
Return on Equity (TTM) | -0.53% | 0.05% |
Debt to Equity (MRQ) | 22.18 | 74.74 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $2.68 | $34.05 |
Cash per Share (MRQ) | $0.30 | $1.42 |
Operating Cash Flow (TTM) | $57.66M | $424.81M |
Levered Free Cash Flow (TTM) | $87.15M | $-267,134,000 |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Guardian Pharmacy vs Acadia Healthcare
Metric | GRDN | ACHC |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 90.13 | 13.80 |
Forward P/E | 28.59 | 5.72 |
PEG Ratio | -6.39 | -0.22 |
Price to Sales (TTM) | 1.19 | 0.60 |
Price to Book (MRQ) | 9.28 | 0.62 |
Market Capitalization | ||
Market Capitalization | $1.57B | $1.94B |
Enterprise Value | $1.60B | $4.36B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.21 | 1.35 |
Enterprise to EBITDA | -43.48 | 6.76 |
Risk & Other Metrics | ||
Beta | N/A | 0.88 |
Book Value per Share (MRQ) | $2.68 | $34.05 |
Financial Statements Comparison: Guardian Pharmacy vs Acadia Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | GRDN | ACHC |
---|---|---|
Revenue/Sales | $329.31M | $770.51M |
Cost of Goods Sold | $264.96M | $28.34M |
Gross Profit | $64.35M | $742.16M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $13.01M | $78.50M |
EBITDA | $18.54M | $125.53M |
Pre-Tax Income | $13.11M | $13.47M |
Income Tax | $3.83M | $4.40M |
Net Income (Profit) | $9.27M | $9.06M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | GRDN | ACHC |
---|---|---|
Cash & Equivalents | $14.00M | $91.24M |
Total Current Assets | $166.04M | $638.95M |
Total Current Liabilities | $145.30M | $473.35M |
Long-Term Debt | $21.79M | $2.29B |
Total Shareholders Equity | $163.22M | $3.17B |
Retained Earnings | $26.57M | $348.45M |
Property, Plant & Equipment | $78.92M | $597.87M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | GRDN | ACHC |
---|---|---|
Operating Cash Flow | $20.61M | $30.01M |
Capital Expenditures | $-5.81M | $43,000 |
Free Cash Flow | $11.75M | $-163.15M |
Debt Repayment | $-1.13M | $-1.71B |
Common Stock Repurchase | N/A | $-46.88M |
Short Interest & Institutional Ownership Analysis
Metric | GRDN | ACHC |
---|---|---|
Shares Short | 515,096 | 10.54M |
Short Ratio | 3.03 | 6.05 |
Short % of Float | 0.04% | 0.14% |
Average Daily Volume (10 Day) | 224,706 | 3,251,860 |
Average Daily Volume (90 Day) | 158,499 | 2,130,137 |
Shares Outstanding | 63.29M | 91.78M |
Float Shares | 19.46M | 90.63M |
% Held by Insiders | 0.15% | 0.02% |
% Held by Institutions | 0.83% | 1.16% |
Dividend Analysis & Yield Comparison: Guardian Pharmacy vs Acadia Healthcare
Metric | GRDN | ACHC |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |